Sri Lanka is bracing for a global biotechnology boom as the Government spearheads key initiatives with private sector participation.
The recently set-up Sri Lanka Institute of Biotechnology Ltd., (SLIBTEC), a Government-owned company is now functioning under the purview of the Ministry of Technology.
The State Ministry of Digital Technology and Entrepreneur Development is tasked with championing the country’s ambitious foray into commercially harnessing biological processes for industrial and other purposes.
SLIBTEC’s primary objective is to promote biotech research and innovation in Sri Lanka and to support the development of biotech industries.
SLIBTEC facilitates a state-of-the-art research and innovation ecosystem to increase biotech product exports. SLIBTEC is an ecosystem conducive for high-end biotech innovation created by the continued adoption of cutting-edge technologies in dedicated facilities with support systems, enabling a vibrant research, development and innovation culture.
Further, by including customised biotechnology incubation and manufacturing in one physical location, while adhering to global best practices, including sustainability concepts in all spheres of activities, SLIBTEC provides a linear research and development platform for the biotechnology business.
The SLIBTEC will concomitantly be developed as two main components: SLIBTEC Park and SLIBTEC Research.
To kick off the initiative, Expression of Interests (eois) has been called to set up the SLIBTEC Park at Pitipana – Homagama.
The innovation park is aimed at setting up hi-tech biotech industries to produce globally competitive products and services for local and international markets.
The Park will span around 13 acres of the total area assigned (100 acres) for SLIBTEC and will have essential facilities for biotechnology manufacturing and start-up operations adhering to green concepts.
Basic requirements such as infra-roads, water, electricity, communication, waste management and environmental approvals are included in the innovation park facility package. Office and lab space for start-up operations and warehouse facilities will be leased on a long-term basis to private biotech entities.
The SLIBTEC Park benefits from being located in an environment with other high-end technologies, including cutting-edge research and development, and independently functioning core facility that will synergise the innovation ecosystem for high-end developments.
EOIs are invited on or before 16 August, from qualified companies, to be a tenant of SLIBTEC, to manufacture biotech products in the SLIBTEC Park, and to utilise incubator and warehouse facilities.